B-cell Precursor Acute Lymphoblastic Leukemia (ALL): Clinical Trials

2 trials for B-cell Precursor Acute Lymphoblastic Leukemia (ALL), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1

Follow B-cell Precursor Acute Lymphoblastic Leukemia (ALL): new trials by email Literature Review of B-cell Precursor Acute Lymphoblastic Leukemia (ALL) trials Research Report on B-cell Precursor Acute Lymphoblastic Leukemia (ALL)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
BEBT-908 in MEF2D-Rearranged Relapsed/Refractory or MRD-Positive B-Cell Precursor Acute Lymphoblastic Leukemia
Ifupinostat Hydrochloride - B-cell Precursor Acute Lymphoblastic Leukemia (ALL)
Phase 1RecruitingThe First Affiliated Hospital of Soochow University152026-09-012026-10-02
Historical Data Analysis of Complete Remission in Children With R/R Acute Lymphoblastic Leukemia (ALL)
Other: not applicable - observational study - B-cell Precursor Acute Lymphoblastic Leukemia (ALL)
CompletedAmgen2072014-12-092020-05-06

Narrower conditions

Leukemia (1)  ·  Lymphoma (1)

Broader conditions

Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Lymphatic Diseases (1)  ·  Lymphoproliferative Disorders (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)

Interventions

BEBT-908 (1)

Sponsors

Amgen (1)  ·  The First Affiliated Hospital of Soochow University (1)

Countries

Austria (1)  ·  China (1)  ·  Germany (1)  ·  Italy (1)